Mesa Laboratories Inc. (MLAB)
NASDAQ: MLAB
· Real-Time Price · USD
111.82
-0.15 (-0.13%)
At close: May 22, 2025, 11:44 AM
Mesa Laboratories Revenue Breakdown
| Period Ending | Mar 31, 2024 |
|---|---|
| Biopharmaceutical Development Revenue | 40.71M |
| Biopharmaceutical Development Revenue Growth | n/a |
| Calibration Solutions Revenue | 47.76M |
| Calibration Solutions Revenue Growth | n/a |
| Clinical Genomics Revenue | 52.59M |
| Clinical Genomics Revenue Growth | n/a |
| Sterilization and Disinfection Control Revenue | 75.12M |
| Sterilization and Disinfection Control Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.92M | 27.31M | 23.52M | 22.63M | 29.18M | 27.18M | 27.04M | 27.68M | 24.57M | 27.4M | 30.23M | 30.04M | 25.98M | 16.33M | 16.28M | 17.68M | 17.93M | 14.4M | 14.17M | 15.38M | 15.67M | 9.98M | 9.73M | 10.98M | 9.79M | 9.3M | 9.49M | 8.64M | 8.2M | 8.7M | 9.54M | 7.41M | 8.29M | 8.67M | 8.4M | 8.11M | 7.4M | 9.07M | 6.54M | 6.48M |
| Selling, General, and Administrative Revenue Growth | +5.89% | +16.13% | +3.95% | -22.44% | +7.36% | +0.52% | -2.33% | +12.68% | -10.35% | -9.37% | +0.64% | +15.66% | +59.10% | +0.30% | -7.91% | -1.39% | +24.48% | +1.60% | -7.85% | -1.86% | +57.08% | +2.56% | -11.43% | +12.24% | +5.25% | -2.03% | +9.79% | +5.44% | -5.77% | -8.77% | +28.73% | -10.64% | -4.35% | +3.13% | +3.63% | +9.56% | -18.39% | +38.77% | +0.93% | n/a |
| Research and Development Revenue | 5.05M | 4.63M | 4.74M | 5.2M | 4.29M | 4.99M | 4.81M | 5M | 4.8M | 4.99M | 5.7M | 5.18M | 5.16M | 2.61M | 2.81M | 2.67M | 2.71M | 2.41M | 2.6M | 2.31M | 2.11M | 915K | 1.02M | 967K | 860K | 842K | 837K | 749K | 752K | 885K | 1.15M | 1.22M | 861K | 1.04M | 1.03M | 1.04M | 975K | 991K | 963K | 835K |
| Research and Development Revenue Growth | +9.04% | -2.13% | -8.98% | +21.15% | -14.00% | +3.78% | -3.86% | +4.32% | -3.85% | -12.47% | +10.06% | +0.29% | +97.63% | -7.04% | +5.16% | -1.18% | +12.05% | -7.01% | +12.33% | +9.53% | +130.60% | -10.21% | +5.38% | +12.44% | +2.14% | +0.60% | +11.75% | -0.40% | -15.03% | -23.24% | -5.18% | +41.23% | -17.61% | +0.97% | -0.77% | +6.97% | -1.61% | +2.91% | +15.33% | n/a |
| Sales and Marketing Revenue | 10.45M | 9.85M | 10.12M | 10.26M | 9.74M | 9.65M | 8.98M | 9.78M | 8.44M | 9.2M | 10.02M | 9.85M | 8.96M | 4.64M | 4.86M | 5.87M | 4.75M | 3.79M | 4.08M | 4.36M | 4.07M | 2.27M | 2.21M | 2.51M | 2.05M | 1.8M | 1.89M | 1.91M | 1.94M | 2.29M | 2.68M | 2.43M | 2.41M | 2.69M | 2.42M | 1.9M | 1.52M | 2.29M | 1.8M | 2M |
| Sales and Marketing Revenue Growth | +6.10% | -2.64% | -1.42% | +5.39% | +0.90% | +7.51% | -8.21% | +15.91% | -8.29% | -8.21% | +1.75% | +9.97% | +92.94% | -4.43% | -17.18% | +23.42% | +25.54% | -7.09% | -6.56% | +7.23% | +78.85% | +2.99% | -12.10% | +22.30% | +13.86% | -4.55% | -1.25% | -1.44% | -15.12% | -14.59% | +10.34% | +0.79% | -10.58% | +11.14% | +27.85% | +24.98% | -33.70% | +27.18% | -10.01% | n/a |